Phase 3CompletedINTERVENTIONAL
Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
ClinicalTrials.gov · NCT00395746 · Registry updated: 2017-03-08
- Condition / research focus
- Diabetes; Diabetes Mellitus, Type 2
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- Japan
- Registry dates and results
- Start: 2006-10. Completion: 2008-05 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- sulfonylurea (drug)
- liraglutide (drug)
- liraglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported